Recently, small case series have described successful off-label use of transcatheter aortic valve implantation (TAVI) in patients with degenerated bioprosthetic valves in mitral position. We here report the case of a 78-year-old female patient who underwent TAVI for severe aortic stenosis and transapical valve-in-valve implantation for degenerated mitral bioprosthesis. There was no evidence of intraprosthetic regurgitation and/or paraprosthetic leaks on control angiography and transesophageal echocardiography. The postoperative course was uneventful. Following accurate patient selection and evaluation by an experienced multidisciplinary team, the transcatheter approach for double valve implantation in aortic and mitral position may represent a viable treatment option for those high-risk patients who otherwise would be inoperable. © 2012 Il Pensiero Scientifico Editore.

Recurrent aortic and mitral valvulopathy in high-risk patients: Two-step Transcatheter aortic valve and mitral valve-in-valve implantation in two step

Santarpino G.
;
2012-01-01

Abstract

Recently, small case series have described successful off-label use of transcatheter aortic valve implantation (TAVI) in patients with degenerated bioprosthetic valves in mitral position. We here report the case of a 78-year-old female patient who underwent TAVI for severe aortic stenosis and transapical valve-in-valve implantation for degenerated mitral bioprosthesis. There was no evidence of intraprosthetic regurgitation and/or paraprosthetic leaks on control angiography and transesophageal echocardiography. The postoperative course was uneventful. Following accurate patient selection and evaluation by an experienced multidisciplinary team, the transcatheter approach for double valve implantation in aortic and mitral position may represent a viable treatment option for those high-risk patients who otherwise would be inoperable. © 2012 Il Pensiero Scientifico Editore.
2012
Aortic valve stenosis; Bioprosthesis; Heart valve prosthesis implantation; Mitral valve insufficiency; Aged; Aortic Valve Stenosis; Echocardiography, Transesophageal; Female; Heart Valve Prosthesis Implantation; Humans; Mitral Valve Insufficiency; Prosthesis Failure; Radiography; Reoperation; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Bioprosthesis; Cardiac Catheterization
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.12317/60492
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? ND
social impact